Axon Stock Diversifies Your Portfolio Less Than Its Business Does

Its orders come from police budgets and counter-drone contracts rather than the economic cycle, yet the stock still falls harder than the market on down days.

Axon Enterprise (AXON) has gained 9.6% over the past five trading days while the S&P 500 rose 2.5%, with second quarter 2026 results due on August 5. The urge is to buy ahead of the print. What decides your outcome is not the move around the print but how much of Axon’s return is its own story rather than a repeat of the index fund you already own.

What A 0.42 Correlation Says About Who Buys From Axon

Over five years Axon’s daily moves carry a 0.42 correlation with the S&P 500: it shares part of the market’s direction and keeps much of its behavior for itself. TASER 10 and body cameras go into police budgets a city council may have to vote on; Dedrone counter-drone systems and Fusus camera networks go to international agencies and enterprise sites. Those orders clear on procurement calendars, not the economic cycle the index tracks. Over that window Axon compounded at 25% a year against 13.0% for the index, while gold, the classic uncorrelated asset, returned 17.2% at a 0.01 correlation to Axon, real independence at a lower return. Axon’s overlap with the market can reach you twice: aerospace and defense funds hold it too.

Why Axon Falls Harder Than The Market On Down Days

That independence shows up more in the order book than in the share price. Over the past year Axon captured about 104% of the index’s gain on up days but about 171% of its loss on down days: it matches the market on the way up and overshoots on the way down. Its 49% five-year volatility is nearly three times the index’s 17.2% volatility. At 224 times earnings against a median near 24 for the index, you are paying for Dedrone volumes the company says it cannot ship fast enough and Fusus deployments still spreading through enterprise, not today’s profits. Expectations reaching that far out reprice sharply when risk appetite turns, the same moment the rest of your portfolio is falling.

Own Axon For Its Own Story, Not For A Calmer Portfolio

Axon is a partial diversifier and a good one, its return driven by demand the index does not control. What it is not is a stabilizer. The business kept compounding while the stock did not: revenue rose 34% year over year in the first quarter of 2026, a ninth straight quarter above 30%, while the shares fell 24% over the past twelve months. Hold it as a return engine, not ballast, and before you add, look at what the options market expects around the August 5 report. The signal to watch is whether Dedrone shipments catch up with Dedrone bookings.

A Holding That Amplifies Down Days Needs A System Around It

Owning something that absorbed about 171% of the market’s down-day losses over the past year is a portfolio question, not a stock question. The Trefis High Quality Portfolio chases the same compounding with far less of that swing. That portfolio has a track record of outpacing the three major indices – the S&P 500, S&P Mid-cap, and Russell 2000.